ASKA Pharmaceutical Hits Day High with 7.16% Surge in Stock Price

ASKA Pharmaceutical Holdings Co., Ltd. has experienced a significant uptick in its stock performance today, rising by 7.16% as of April 1, 2026. The stock reached an intraday high of JPY 2,529.00, reflecting a strong day of trading activity. In comparison to the broader market, ASKA's one-day performance outpaced the Japan Nikkei 225, which recorded a gain of 5.24%. Over the past week, ASKA has shown a robust increase of 9.81%, while its monthly performance stands at 1.48%. Year-to-date, the stock has delivered a notable return of 24.09%, significantly outperforming the Nikkei's 6.75% gain. Despite these positive short-term trends, ASKA's longer-term performance metrics indicate some challenges. Over the past year, the stock has returned only 1.15%, lagging behind the Nikkei 225's impressive 43.37% return. The company's market capitalization is currently JPY 61,381 million, and it operates within the Pharmaceuticals & Biotechnology sector, characterized as a small-cap entity. Key financial metrics include a P/E ratio of 13.00 and a return on equity of 7.81%.